EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Frailty and Oncology: An Increasingly Common Combination

Yanira Hernández-Aguiar iD, Ángel Becerra-Bolaños iD, Aurelio Rodríguez-Pérez iD

Cancer Medicine · 2026-01 · 15 (1)

DOI: 10.1002/cam4.71499 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 26.12.2025. Verfasst von Yanira Hernández-Aguiar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Intensive Care and Pain Medicine, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spa…. Hauptthemen laut MEDLINE: Frailty, Neoplasms, Medical Oncology. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Frailty is defined by a reduction in physiological reserve and an increased vulnerability to stressors. In oncology, frailty is highly prevalent and has been consistently associated with a worse prognosis. The aim of this manuscript is to understand the interaction between frailty and cancer to optimise therapeutic decision‐making and improve patient‐centred outcomes.

Methods

A narrative literature review was conducted using the PubMed database, with articles published up to July 2025 included. The search terms used included "frailty", "oncology", "cancer", "malignancy", "diagnosis", "optimisation", "treatment" and "prognosis". In accordance with the protocol, the following documents were prioritised: clinical guidelines, systematic and narrative reviews, observational studies, and randomised clinical trials.

Results

Frailty has been shown to independently predict postoperative morbidity, chemotherapy toxicity, functional decline, and mortality. This can result in both undertreatment and overtreatment. Consequently, frailty assessment has emerged as a cornerstone of personalised oncology, enabling treatment individualisation beyond tumor characteristics alone. While a Comprehensive Geriatric Assessment remains the gold standard for frailty evaluation, screening tools should be used to facilitate risk stratification in routine practice. Incorporating frailty into decision‐making processes has been shown to reduce inappropriate undertreatment and overtreatment, improve treatment tolerance, and facilitate shared decision‐making. Multimodal, patient‐centred interventions, such as exercise, nutritional support, medication optimisation, psychosocial care, and early palliative integration, mitigate frailty, enhance quality of life, and support adherence to individualised therapeutic plans. Oncogeriatric models of care further operationalise personalised medicine by coordinating these interventions within multidisciplinary teams.

Conclusion

It is crucial to acknowledge frailty as a pivotal clinical variable, rather than considering it a contraindication to cancer treatment. Health systems should promote structured frailty evaluation, professional training, and institutional pathways to ensure equitable, patient‐centred management of frail individuals with cancer. Integrating frailty into oncology clinical practice operationalises personalised medicine by shifting the focus from treating the disease to treating the whole patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyNeoplasmsMedical OncologyHumansGeriatric AssessmentPrognosisClinical Decision-MakingAgedPrecision Medicine

Stichwörter der Autor:innen

frailtypalliative careprehabilitationprognosisscreeningtherapeutic optimization

Autor:innen und Institutionen

  • Department of Anesthesiology, Intensive Care and Pain Medicine, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain.
  • Department of Medical and Surgical Sciences, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.

ORCID-Profile: Yanira Hernández-Aguiar, Ángel Becerra-Bolaños, Aurelio Rodríguez-Pérez

Zitieren

APA

Hernández-Aguiar, Y., Becerra-Bolaños, Á., & Rodríguez-Pérez, A. (2026). Frailty and Oncology: An Increasingly Common Combination. Cancer Medicine, 15(1). https://doi.org/10.1002/cam4.71499

Vancouver

Hernández-Aguiar Y, Becerra-Bolaños Á, Rodríguez-Pérez A. Frailty and Oncology: An Increasingly Common Combination. Cancer Medicine. 2026;15(1). doi:10.1002/cam4.71499

BibTeX
@article{HernndezAguiar2026,
  author = {Hernández-Aguiar, Yanira and Becerra-Bolaños, Ángel and Rodríguez-Pérez, Aurelio},
  title = {Frailty and Oncology: An Increasingly Common Combination},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1002/cam4.71499}
}
Kostenlos starten →